Exact Mass: 434.2628

Exact Mass Matches: 434.2628

Found 500 metabolites which its exact mass value is equals to given mass value 434.2628, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Oleoylglycerone phosphate

1-oleoyl-2-lyso-glycerone phosphate

C21H39O7P (434.2433)


   

Glutathionylspermidine

N1-(γ-L-Glutamyl-L-cysteinyl-glycyl)-spermidine

C17H34N6O5S (434.2311)


The spermidine amide of glutathione.

   

Lexibulin

CYT997(Lexibulin)

C24H30N6O2 (434.243)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

2,5-dimethyl-8-(propan-2-yl)-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C is found in mushrooms. (12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C is a constituent of Hericium erinaceum (lions mane)

   

LysoPA(0:0/18:2(9Z,12Z))

{3-hydroxy-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy}phosphonic acid

C21H39O7P (434.2433)


LysoPA(0:0/18:2(9Z,12Z)) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

   

LysoPA(18:2(9Z,12Z)/0:0)

{2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy}phosphonic acid

C21H39O7P (434.2433)


LPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293) [HMDB] LysoPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

   

Polysorbate 60

(2R)-2-[(2R,3R,4S)-3,4-Bis(2-hydroxyethoxy)oxolan-2-yl]-2-hydroxyethyl dodecanoic acid

C22H42O8 (434.288)


Polysorbate 60 is an emulsifier, opacifier, protective coating, dough conditioner, dispersant, wetting agent, stabiliser, defoamer, poultry scald agent, flavour.Polysorbates are a class of emulsifiers used in some pharmaceuticals and food preparation. They are often used in cosmetics to solubilize essential oils into water-based products. Polysorbates are oily liquids derived from PEG-ylated sorbitan (a derivative of sorbitol) esterified with fatty acids. (Wikipedia). Emulsifier, opacifier, protective coating, dough conditioner, dispersant, wetting agent, stabiliser, defoamer, poultry scald agent, flavour.

   

Butyl oleate sulfate

{[(9E)-18-butoxy-18-oxooctadec-9-en-1-yl]oxy}sulphonic acid

C22H42O6S (434.2702)


Surfactant. Butyl oleate sulfate is used in dehydration of grapes to produce raisins and as a coating for citrus fruits. Surfactant. It is used in dehydration of grapes to produce raisins and as a coating for citrus fruits

   

Erinacine C

13-(hydroxymethyl)-2,5-dimethyl-8-(propan-2-yl)-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


Erinacine C is found in mushrooms. Erinacine C is a metabolite of Hericium erinaceum (lions mane).

   

Kaspar

8-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione

C26H34N4O2 (434.2682)


   

Urea, N-butyl-N'-(2-(3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxy)-6-methylphenyl)-

Urea, N-butyl-N-(2-(3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxy)-6-methylphenyl)-

C26H34N4O2 (434.2682)


   

Lexibulin

1-ethyl-3-[2-methoxy-4-[5-methyl-4-[[(1S)-1-pyridin-3-ylbutyl]amino]pyrimidin-2-yl]phenyl]urea

C24H30N6O2 (434.243)


   

Ribociclib

7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide

C23H30N8O (434.2542)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C25H38O6 (434.2668)


MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

(2S)-2,3-dihydroxypropyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C25H38O6 (434.2668)


MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

1,3-Dihydroxypropan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C25H38O6 (434.2668)


MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

1,3-Dihydroxypropan-2-yl (4Z,7Z,10R,11E,13Z,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C25H38O6 (434.2668)


MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   
   

N,N-Didemethylalfileramine

N,N-Didemethylalfileramine

C28H38N2O2 (434.2933)


   

Crinatusin A1

Crinatusin A1

C28H34O4 (434.2457)


   

Clibadic acid

Clibadic acid

C25H38O6 (434.2668)


   

3beta-Malonyloxy-15-acetoxy-ent-labda-7,13E-dien methylester

3beta-Malonyloxy-15-acetoxy-ent-labda-7,13E-dien methylester

C25H38O6 (434.2668)


   

Dictamnoside J

Dictamnoside J

C21H38O9 (434.2516)


   

Iriomoteolide 3a

Iriomoteolide 3a

C25H38O6 (434.2668)


   

Lincomycin S

N,S-Didemethyl-N,S-diethyllincomycin

C20H38N2O6S (434.245)


   
   

Philadelphinone

Philadelphinone

C25H38O6 (434.2668)


   

Crinatusin A2

Crinatusin A2

C28H34O4 (434.2457)


   

Vladimuliecin A

Vladimuliecin A

C25H38O6 (434.2668)


   
   

methyl 2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate

methyl 2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate

C27H34N2O3 (434.2569)


   

(all-Z)-5,7-dihydroxy-2-nonadeca-4,7,10,13,16-pentenyl-chromone|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaen-1-yl)-4H-chromen-4-one|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenyl)-4H-chromen-4-one|5,7-dihydroxy-2-(4Z,7Z,10Z,13Z,16Z-nonadecapentaenyl)chromone

(all-Z)-5,7-dihydroxy-2-nonadeca-4,7,10,13,16-pentenyl-chromone|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaen-1-yl)-4H-chromen-4-one|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenyl)-4H-chromen-4-one|5,7-dihydroxy-2-(4Z,7Z,10Z,13Z,16Z-nonadecapentaenyl)chromone

C28H34O4 (434.2457)


   

12-angeloxy-8-O-angeloylshiromodiol

12-angeloxy-8-O-angeloylshiromodiol

C25H38O6 (434.2668)


   

1alpha-(beta-D-glucopyranosyloxy)eudesma-3alpha,4beta,11-triol

1alpha-(beta-D-glucopyranosyloxy)eudesma-3alpha,4beta,11-triol

C21H38O9 (434.2516)


   

9,10-diangeloyloxy-11-hydroxy-10,11-dihydrobrickelliol

9,10-diangeloyloxy-11-hydroxy-10,11-dihydrobrickelliol

C25H38O6 (434.2668)


   
   

2-Benzoyl-3,5-dihydroxy-4,4,6-tris(3-methyl-2-butenyl)-2,5-cyclohexadien-1-one

2-Benzoyl-3,5-dihydroxy-4,4,6-tris(3-methyl-2-butenyl)-2,5-cyclohexadien-1-one

C28H34O4 (434.2457)


   

Tri-Ac-(3beta,5alpha,16alpha,17alpha)-Androstane-3,16,17-triol

Tri-Ac-(3beta,5alpha,16alpha,17alpha)-Androstane-3,16,17-triol

C25H38O6 (434.2668)


   

18,19-Dihydrousambarensine

18,19-Dihydrousambarensine

C29H30N4 (434.247)


   

15-(3-Hydroxy-2-methylbutanoyl)-(ent-15beta)-9, 15-Dihydroxy-16-kauren-19-oic acid

15-(3-Hydroxy-2-methylbutanoyl)-(ent-15beta)-9, 15-Dihydroxy-16-kauren-19-oic acid

C25H38O6 (434.2668)


   

6alpha,8alpha-dihydroxy-23-carboxy-labd-13(14),17-dien-16,19-olide

6alpha,8alpha-dihydroxy-23-carboxy-labd-13(14),17-dien-16,19-olide

C25H38O6 (434.2668)


   
   

16-(4,9-dihydro-3H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|3,4-Dihydro-usambarensin

16-(4,9-dihydro-3H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|3,4-Dihydro-usambarensin

C29H30N4 (434.247)


   

seco-pseudopterosin J

seco-pseudopterosin J

C25H38O6 (434.2668)


   

7-oxo-13alpha-methoxy-8,11,13-abietatriene-18-succinic acid|abiesadine U

7-oxo-13alpha-methoxy-8,11,13-abietatriene-18-succinic acid|abiesadine U

C25H38O6 (434.2668)


   

3,21-Di-Ac-(3alpha,5beta)-3,14,21-Trihydroxypregnan-20-one

3,21-Di-Ac-(3alpha,5beta)-3,14,21-Trihydroxypregnan-20-one

C25H38O6 (434.2668)


   

bakkenolide-O

bakkenolide-O

C25H38O6 (434.2668)


   

4-farnesyl-3,5,4-trihydroxybibenzyl

4-farnesyl-3,5,4-trihydroxybibenzyl

C29H38O3 (434.2821)


   
   

chabrolonaphthoquinone

chabrolonaphthoquinone

C28H34O4 (434.2457)


   

3,21-Di-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one

3,21-Di-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one

C25H38O6 (434.2668)


   

17-Angeloyl-(ent-12alpha,16alphaOH)-12,16,17-Trihydroxy-19-kauranoic acid|ent-12alpha,16alpha-dihydroxy-17-angeloxykauran-19-oic acid

17-Angeloyl-(ent-12alpha,16alphaOH)-12,16,17-Trihydroxy-19-kauranoic acid|ent-12alpha,16alpha-dihydroxy-17-angeloxykauran-19-oic acid

C25H38O6 (434.2668)


   

8alpha,15(S),23alpha-trihydroxy-23,6alpha-epoxy-labd-13(14),17-dien-16(S),19-olide

8alpha,15(S),23alpha-trihydroxy-23,6alpha-epoxy-labd-13(14),17-dien-16(S),19-olide

C25H38O6 (434.2668)


   

ligulamulienin B

ligulamulienin B

C29H38O3 (434.2821)


   

4-Depropyl-4-pentyl-Lincomycin,BAN,INN

4-Depropyl-4-pentyl-Lincomycin,BAN,INN

C20H38N2O6S (434.245)


   

petrosaspongiolide G

petrosaspongiolide G

C25H38O6 (434.2668)


   

Secopseudopterosin A

Secopseudopterosin A

C25H38O6 (434.2668)


   

(1RS,5RS,7RS)-3-benzoyl-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione|garciniaphenone

(1RS,5RS,7RS)-3-benzoyl-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione|garciniaphenone

C28H34O4 (434.2457)


   

N,N-demethylisoalfileramine

N,N-demethylisoalfileramine

C28H38N2O2 (434.2933)


   

(10R,6E)-7,11-dimethyl-3-methylene-6-dodecaene-1,2,10,11-tetraol 10-O-beta-D-glucopyranoside|trikamsesquiside A

(10R,6E)-7,11-dimethyl-3-methylene-6-dodecaene-1,2,10,11-tetraol 10-O-beta-D-glucopyranoside|trikamsesquiside A

C21H38O9 (434.2516)


   

2-hydroxy-3-[(1-oxododecyl)oxy]propyl-beta-D-glucopyranoside

2-hydroxy-3-[(1-oxododecyl)oxy]propyl-beta-D-glucopyranoside

C22H42O8 (434.288)


   

ent-19-(Z)-coumaroyloxylabda-8(17),13(16),14-triene

ent-19-(Z)-coumaroyloxylabda-8(17),13(16),14-triene

C29H38O3 (434.2821)


   

18-O-(E)-p-coumaroylbeyer-15-ene-18-ol|obtsurin B

18-O-(E)-p-coumaroylbeyer-15-ene-18-ol|obtsurin B

C29H38O3 (434.2821)


   

Antibiotic SU4

Antibiotic SU4

C19H38N4O7 (434.274)


   

1,1-trisulfanediyl-bis-undecan-3-one

1,1-trisulfanediyl-bis-undecan-3-one

C22H42O2S3 (434.2347)


   

Na, Nb-Didemethylisoalfileramine|Na,Nb-Di-de-Me-Isoalfileramine

Na, Nb-Didemethylisoalfileramine|Na,Nb-Di-de-Me-Isoalfileramine

C28H38N2O2 (434.2933)


   

bakkenolide-Q

bakkenolide-Q

C25H38O6 (434.2668)


   
   

abiesadine V|methyl 7-oxo-13beta-hydroxy-8,11,13-abietatriene-18-succinate

abiesadine V|methyl 7-oxo-13beta-hydroxy-8,11,13-abietatriene-18-succinate

C25H38O6 (434.2668)


   

7-oxo-7,8-dihydroscutione

7-oxo-7,8-dihydroscutione

C28H34O4 (434.2457)


   

chisosiamensin

chisosiamensin

C28H34O4 (434.2457)


   

Tri-Ac-(3beta,5alpha,6alpha,17alpha)-Androstane-3,6,17-triol

Tri-Ac-(3beta,5alpha,6alpha,17alpha)-Androstane-3,6,17-triol

C25H38O6 (434.2668)


   

longipinane-7beta,8alpha,9alpha-triol-1-one 7-angelate-8-methylbutyrate

longipinane-7beta,8alpha,9alpha-triol-1-one 7-angelate-8-methylbutyrate

C25H38O6 (434.2668)


   

6alpha,8alpha,15(S)-trihydroxy-23-oxo-labd-13(14),17-dien-16(S),19-olide

6alpha,8alpha,15(S)-trihydroxy-23-oxo-labd-13(14),17-dien-16(S),19-olide

C25H38O6 (434.2668)


   

9beta-acetoxy-11beta,12beta-epoxy-13alpha-hydroxy-3alpha-propionoxy-1beta,8beta-trinervit-15(17)-ene

9beta-acetoxy-11beta,12beta-epoxy-13alpha-hydroxy-3alpha-propionoxy-1beta,8beta-trinervit-15(17)-ene

C25H38O6 (434.2668)


   

2alpha-Angeloyloxy-3beta-(2-methylbutanoyloxy)isodrimeninol

2alpha-Angeloyloxy-3beta-(2-methylbutanoyloxy)isodrimeninol

C25H38O6 (434.2668)


   

norzyggomphic acid

norzyggomphic acid

C29H38O3 (434.2821)


   

(ent-15beta)-2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid|2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid

(ent-15beta)-2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid|2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid

C25H38O6 (434.2668)


   

8-Angeloyl,9-(3-mehtylbutanoyl)-(3beta,8alpha,9beta,10b)-8,9,10-Trihydroxy-5-longipinanone

8-Angeloyl,9-(3-mehtylbutanoyl)-(3beta,8alpha,9beta,10b)-8,9,10-Trihydroxy-5-longipinanone

C25H38O6 (434.2668)


   

11-hydroxy-8,11,13-abietatriene 12-O-beta-D-xylopyranoside

11-hydroxy-8,11,13-abietatriene 12-O-beta-D-xylopyranoside

C25H38O6 (434.2668)


   

20-alpha-hydroxyscutione

20-alpha-hydroxyscutione

C28H34O4 (434.2457)


   

phenylalanylisoleucylarginine

phenylalanylisoleucylarginine

C21H34N6O4 (434.2641)


   

isoleucylphenylalanylarginine

isoleucylphenylalanylarginine

C21H34N6O4 (434.2641)


   
   
   
   

13-oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid

NCGC00381173-01!13-oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid

C21H38O9 (434.2516)


   

[(2R)-2-[(E,2S,4R)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl] (2E,4E,6S)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

[(2R)-2-[(E,2S,4R)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl] (2E,4E,6S)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)


   

19,20-dihydrousambarensine

19,20-dihydrousambarensine

C29H30N4 (434.247)


   

Bis[2-(2-butoxyethoxy)ethyl] adipate

Bis[2-(2-butoxyethoxy)ethyl] hexandioate

C22H42O8 (434.288)


CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9768; ORIGINAL_PRECURSOR_SCAN_NO 9763 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9764; ORIGINAL_PRECURSOR_SCAN_NO 9760 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9787; ORIGINAL_PRECURSOR_SCAN_NO 9784 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9800; ORIGINAL_PRECURSOR_SCAN_NO 9798 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9802; ORIGINAL_PRECURSOR_SCAN_NO 9800 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9812; ORIGINAL_PRECURSOR_SCAN_NO 9809

   

Ala Phe Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Ala Val Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Ala Val Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Cys Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]hexanoic acid

C17H34N6O5S (434.2311)


   

Cys Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}hexanoic acid

C17H34N6O5S (434.2311)


   

Cys Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]hexanamido]acetic acid

C17H34N6O5S (434.2311)


   

Phe Ala Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Phe Gly Ile Val

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-methylpentanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Phe Gly Leu Val

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-4-methylpentanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Phe Gly Val Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-methylbutanamido]-3-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Phe Gly Val Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-methylbutanamido]-4-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Phe Ile Gly Val

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]acetamido}-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Phe Ile Val Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]acetic acid

C22H34N4O5 (434.2529)


   

Phe Leu Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]acetamido}-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Phe Leu Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]acetic acid

C22H34N4O5 (434.2529)


   

Phe Val Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]propanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Phe Val Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]acetamido}-3-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Phe Val Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]acetamido}-4-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Phe Val Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]acetic acid

C22H34N4O5 (434.2529)


   

Phe Val Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]acetic acid

C22H34N4O5 (434.2529)


   

Phe Val Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylbutanamido]propanoic acid

C22H34N4O5 (434.2529)


   

Gly Cys Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]hexanoic acid

C17H34N6O5S (434.2311)


   

Gly Phe Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Gly Phe Leu Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Gly Phe Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Gly Phe Val Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Gly Ile Phe Val

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Gly Ile Val Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Gly Lys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]hexanoic acid

C17H34N6O5S (434.2311)


   

Gly Lys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanamido]-3-sulfanylpropanoic acid

C17H34N6O5S (434.2311)


   

Gly Leu Phe Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Gly Leu Val Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Gly Val Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Gly Val Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Gly Val Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Gly Val Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Ile Phe Gly Val

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]acetamido}-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Ile Phe Val Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]acetic acid

C22H34N4O5 (434.2529)


   

Ile Gly Phe Val

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-phenylpropanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Ile Gly Val Phe

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-methylbutanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Ile Thr Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C18H34N4O8 (434.2377)


   

Ile Val Phe Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]acetic acid

C22H34N4O5 (434.2529)


   

Ile Val Gly Phe

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]acetamido}-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Lys Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

C17H34N6O5S (434.2311)


   

Lys Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

C17H34N6O5S (434.2311)


   

Lys Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

C17H34N6O5S (434.2311)


   

Lys Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

C17H34N6O5S (434.2311)


   

Lys Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

C17H34N6O5S (434.2311)


   

Lys Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

C17H34N6O5S (434.2311)


   
   

Leu Phe Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]acetamido}-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Leu Phe Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]acetic acid

C22H34N4O5 (434.2529)


   

Leu Gly Phe Val

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-phenylpropanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Leu Gly Val Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-methylbutanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   
   
   

Leu Thr Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C18H34N4O8 (434.2377)


   

Leu Val Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]acetic acid

C22H34N4O5 (434.2529)


   

Leu Val Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]acetamido}-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   
   
   
   
   
   
   

Thr Ile Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C18H34N4O8 (434.2377)


   

Thr Leu Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C18H34N4O8 (434.2377)


   

Thr Thr Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C18H34N4O8 (434.2377)


   

Thr Thr Leu Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C18H34N4O8 (434.2377)


   

Thr Thr Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C18H34N4O8 (434.2377)


   

Thr Thr Thr Leu

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C18H34N4O8 (434.2377)


   

Val Ala Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Val Ala Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Val Phe Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]propanamido]-3-methylbutanoic acid

C22H34N4O5 (434.2529)


   

Val Phe Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]acetamido}-3-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Val Phe Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]acetamido}-4-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Val Phe Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]acetic acid

C22H34N4O5 (434.2529)


   

Val Phe Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]acetic acid

C22H34N4O5 (434.2529)


   

Val Phe Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylbutanamido]propanoic acid

C22H34N4O5 (434.2529)


   

Val Gly Phe Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-phenylpropanamido]-3-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Val Gly Phe Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-phenylpropanamido]-4-methylpentanoic acid

C22H34N4O5 (434.2529)


   

Val Gly Ile Phe

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-methylpentanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Val Gly Leu Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-4-methylpentanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Val Ile Phe Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]acetic acid

C22H34N4O5 (434.2529)


   

Val Ile Gly Phe

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]acetamido}-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Val Leu Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]acetic acid

C22H34N4O5 (434.2529)


   

Val Leu Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]acetamido}-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

6-Hydroxysimvastatin

6-Hydroxysimvastatin

C25H38O6 (434.2668)


   

3-Hydroxysimvastatin

3-Hydroxysimvastatin

C25H38O6 (434.2668)


   

6-Hydroxymethylsimvastatin

6-Hydroxymethylsimvastatin

C25H38O6 (434.2668)


   

Val Val Ala Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]propanamido]-3-phenylpropanoic acid

C22H34N4O5 (434.2529)


   

Val Val Phe Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-phenylpropanamido]propanoic acid

C22H34N4O5 (434.2529)


   

1a,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / 1a,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

1a,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / 1a,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)


   

(5Z,7E)-(1R,3R)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatriene3-oxide

(5Z)-1α,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / (5Z)-1α,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)


   

(5Z,7E)-(1R,3S)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatrien 3-oxide

(5Z)-(3S)-1α,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / (5Z)-(3S)-1α,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)


   

1α,25-dihydroxy-22-thiavitamin D3 / 1α,25-dihydroxy-22-thiacholecalciferol

1α,25-dihydroxy-22-thiavitamin D3 / 1α,25-dihydroxy-22-thiacholecalciferol

C26H42O3S (434.2855)


   

1α,25-dihydroxy-22-thia-20-epivitamin D3 / 1α,25-dihydroxy-22-thia-20-epicholecalciferol

1α,25-dihydroxy-22-thia-20-epivitamin D3 / 1α,25-dihydroxy-22-thia-20-epicholecalciferol

C26H42O3S (434.2855)


   

1α,25-dihydroxy-23-thiavitamin D3 / 1α,25-dihydroxy-23-thiacholecalciferol

1α,25-dihydroxy-23-thiavitamin D3 / 1α,25-dihydroxy-23-thiacholecalciferol

C26H42O3S (434.2855)


   

(5Z,7E)-(1S,3R)-24-(dimethylphosphoryl)-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

1α-hydroxy-24-(dimethylphosphoryl)-25,26,27-trinorvitamin D3 / 1α-hydroxy-24-(dimethylphosphoryl)-25,26,27-trinorcholecalciferol

C26H43O3P (434.295)


   

1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / 1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / 1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)


   

(5E,7E)-(1R,3S)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatriene 3-oxide

(5E)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / (5E)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)


   

LPA(18:2)

1-(9Z,12Z-Octadecadienoyl)-phosphatidic acid

C21H39O7P (434.2433)


   

PA(18:2(9Z,12Z)/0:0)

1-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

C21H39O7P (434.2433)


   

CJ 14258

2,5-dimethyl-8-(propan-2-yl)-15,19,23-trioxahexacyclo[18.2.1.0^{2,10}.0^{5,9}.0^{13,22}.0^{16,21}]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


   

Tween 60

(2R)-2-[(2R,3R,4S)-3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-hydroxyethyl dodecanoate

C22H42O8 (434.288)


   

butyl oleate sulfate

{[(9E)-18-butoxy-18-oxooctadec-9-en-1-yl]oxy}sulfonic acid

C22H42O6S (434.2702)


   

Apadoline

13-(hydroxymethyl)-2,5-dimethyl-8-(propan-2-yl)-15,20,22-trioxapentacyclo[12.8.0.0^{2,10}.0^{5,9}.0^{16,21}]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

LPA 18:2

2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate

C21H39O7P (434.2433)


   

1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

(5E,7E)-(1R,3R)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatriene 3-oxide

C26H42O3S (434.2855)


   

(5E)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

(5E,7E)-(1R,3S)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatriene 3-oxide

C26H42O3S (434.2855)


   

(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

(5Z,7E)-(1R,3R)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatriene 3-oxide

C26H42O3S (434.2855)


   

(5Z)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

(5Z,7E)-(1R,3S)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatrien 3-oxide

C26H42O3S (434.2855)


   

1alpha,25-dihydroxy-22-thiavitamin D3

(5Z,7E)-(1S,3R)-9,10-seco-22-thia-5,7,10(19)-cholestatriene-1,3,25-triol

C26H42O3S (434.2855)


   

1alpha,25-dihydroxy-22-thia-20-epivitamin D3

(5Z,7E)-(1S,3R,20R)-9,10-seco-22-thia-5,7,10(19)-cholestatriene-1,3,25-triol

C26H42O3S (434.2855)


   

1alpha,25-dihydroxy-23-thiavitamin D3

(5Z,7E)-(1S,3R)-9,10-seco-23-thia-5,7,10(19)-cholestatriene-1,3,25-triol

C26H42O3S (434.2855)


   

1alpha-hydroxy-24-(dimethylphosphoryl)-25,26,27-trinorvitamin D3

(5Z,7E)-(1S,3R)-24-(dimethylphosphoryl)-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C26H43O3P (434.295)


   

1,5-bis(p-hexyloxyphenyl)-1,4-pentadien-3-one

1,5-bis(p-hexyloxyphenyl)-1,4-pentadien-3-one

C29H38O3 (434.2821)


   

(R)-1-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYL-PROPYL)PIPERIDINE

(R)-1-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYL-PROPYL)PIPERIDINE

C23H34N2O6 (434.2417)


   

4-(TERT-BUTYLDIMETHYLSILANYLOXY)-6-[2-(8-HYDROXY-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)ETHYL]TETRAHYDROPYRAN-2-ONE

4-(TERT-BUTYLDIMETHYLSILANYLOXY)-6-[2-(8-HYDROXY-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)ETHYL]TETRAHYDROPYRAN-2-ONE

C25H42O4Si (434.2852)


   
   

10-CARBOXYDECYL DISULFIDE

10-CARBOXYDECYL DISULFIDE

C22H42O4S2 (434.2524)


   

1-N,4-N-bis(2-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide

1-N,4-N-bis(2-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide

C24H30N6O2 (434.243)


   

methyl 2-[[(2E)-2-benzylideneoctylidene]amino]benzoate

methyl 2-[[(2E)-2-benzylideneoctylidene]amino]benzoate

C27H34N2O3 (434.2569)


   

glycerol propoxylate triglycidyl ether

glycerol propoxylate triglycidyl ether

C21H38O9 (434.2516)


   

5-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE

5-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE

C22H36BClN2O2Si (434.2327)


   

(S)-1-CYCLOHEXYL-4-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)-2-METHYL-2-PHENYLBUTAN-1-ONE

(S)-1-CYCLOHEXYL-4-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)-2-METHYL-2-PHENYLBUTAN-1-ONE

C28H38N2O2 (434.2933)


   
   

2-(4-piperazin-1-ylanilino)-N-(4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)pyrimidine-4-carboxamide

2-(4-piperazin-1-ylanilino)-N-(4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)pyrimidine-4-carboxamide

C25H34N6O (434.2794)


   

1 4-BIS(DIMETHYL(2-(5-NORBORNEN-2-YL)ET&

1 4-BIS(DIMETHYL(2-(5-NORBORNEN-2-YL)ET&

C28H42Si2 (434.2825)


   

sodium hydrogen N-(1-oxooctadecyl)-L-glutamate

sodium hydrogen N-(1-oxooctadecyl)-L-glutamate

C23H41NNaO5 (434.2882)


   

sodium 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]ethyl sulphate

sodium 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]ethyl sulphate

C19H39NaO7S (434.2314)


   

2-FLUORO-5-(AMINOMETHYL)PYRIDINE

2-FLUORO-5-(AMINOMETHYL)PYRIDINE

C24H38N2O5 (434.2781)


   

zinc bis(isoundecanoate)

zinc bis(isoundecanoate)

C22H42O4Zn (434.2374)


   

2-[2-(2,3-dihydro-5-methoxy-2,3,3-trimethyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium acetate

2-[2-(2,3-dihydro-5-methoxy-2,3,3-trimethyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium acetate

C27H34N2O3 (434.2569)


   

magnesium octadecylbenzenesulphonate

magnesium octadecylbenzenesulphonate

C24H42MgO3S (434.2705)


   

4-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE

4-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE

C22H36BClN2O2Si (434.2327)


   

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,formaldehyde,2-[(2-methylphenoxy)methyl]oxirane,phenol

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,formaldehyde,2-[(2-methylphenoxy)methyl]oxirane,phenol

C23H38N4O4 (434.2893)


   

1-N,4-N-bis(3-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide

1-N,4-N-bis(3-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide

C24H30N6O2 (434.243)


   

(2-(7-(2-(4-Cyano-2-fluorophenoxy)ethyl)-9-oxa-3,7-diazabicyclo(3.3.1)non-3-yl)ethyl)carbamic acid tert-butyl ester

(2-(7-(2-(4-Cyano-2-fluorophenoxy)ethyl)-9-oxa-3,7-diazabicyclo(3.3.1)non-3-yl)ethyl)carbamic acid tert-butyl ester

C22H31FN4O4 (434.2329)


   

Oxogestone phenpropionate

Oxogestone phenpropionate

C29H38O3 (434.2821)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

(1R,3S,5E)-5-[(2E)-2-[(3aS,7aR)-1-[1-(2-hydroxy-2-methylpropyl)sulfanylpropan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

(1R,3S,5E)-5-[(2E)-2-[(3aS,7aR)-1-[1-(2-hydroxy-2-methylpropyl)sulfanylpropan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C26H42O3S (434.2855)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

   

Ribociclib

Ribociclib

C23H30N8O (434.2542)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   

LPA(0:0/18:2(9Z,12Z))

LPA(0:0/18:2(9Z,12Z))

C21H39O7P (434.2433)


   

(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide/(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide/(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)


   

1-Oleoyl-sn-glycero-3-phosphate(2-)

1-Oleoyl-sn-glycero-3-phosphate(2-)

C21H39O7P-2 (434.2433)


   

(2R)-2-acetamido-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]sulfanylpropanoate

(2R)-2-acetamido-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]sulfanylpropanoate

C25H40NO3S- (434.2729)


   

(Z)-octadec-11-enoylglycerol 3-phosphate

(Z)-octadec-11-enoylglycerol 3-phosphate

C21H39O7P-2 (434.2433)


   

a 1-Octadec-11-enoyl-sn-glycerol 3-phosphate

a 1-Octadec-11-enoyl-sn-glycerol 3-phosphate

C21H39O7P-2 (434.2433)


   

(2S)-2-amino-5-[[(2R)-1-[[2-[4-(3-aminopropylamino)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid

(2S)-2-amino-5-[[(2R)-1-[[2-[4-(3-aminopropylamino)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid

C17H34N6O5S (434.2311)


   

13-(Hydroxymethyl)-2,5-dimethyl-8-propan-2-yl-15,20,22-trioxapentacyclo[12.8.0.02,10.05,9.016,21]docosa-8,12-diene-17,18-diol

13-(Hydroxymethyl)-2,5-dimethyl-8-propan-2-yl-15,20,22-trioxapentacyclo[12.8.0.02,10.05,9.016,21]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

C25H38O6 (434.2668)


   

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

C25H38O6 (434.2668)


   

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C25H38O6 (434.2668)


   

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C25H38O6 (434.2668)


   

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C25H38O6 (434.2668)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C25H38O6 (434.2668)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C25H38O6 (434.2668)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C25H38O6 (434.2668)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C25H38O6 (434.2668)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

C25H38O6 (434.2668)


   

[3,9-Dicarboxy-2,10-dihydroxy-5-methyl-4,8-dioxo-11-(trimethylazaniumyl)undecyl]-trimethylazanium

[3,9-Dicarboxy-2,10-dihydroxy-5-methyl-4,8-dioxo-11-(trimethylazaniumyl)undecyl]-trimethylazanium

C20H38N2O8+2 (434.2628)


   

Erinacine C

Erinacine C

C25H38O6 (434.2668)


   

N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-5-oxazolecarboxamide

N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-5-oxazolecarboxamide

C25H30N4O3 (434.2318)


   
   

N-[2-(cyclopentylamino)-2-oxoethyl]-4,7-dimethyl-N-(2-methylphenyl)-2-oxo-3H-pyrido[1,2-a]pyrimidine-4-carboxamide

N-[2-(cyclopentylamino)-2-oxoethyl]-4,7-dimethyl-N-(2-methylphenyl)-2-oxo-3H-pyrido[1,2-a]pyrimidine-4-carboxamide

C25H30N4O3 (434.2318)


   

2-Oleoyl-sn-glycero-3-phosphate(2-)

2-Oleoyl-sn-glycero-3-phosphate(2-)

C21H39O7P-2 (434.2433)


   

2-Oxo-3-(stearoyloxy)propyl phosphate

2-Oxo-3-(stearoyloxy)propyl phosphate

C21H39O7P-2 (434.2433)


   

(2E,4E,8S,10E,12Z)-1-[(3E,5S)-5-[(4-hydroxyphenyl)methyl]-2,4-dioxopyrrolidin-3-ylidene]-4,8-dimethyltetradeca-2,4,10,12-tetraen-1-olate

(2E,4E,8S,10E,12Z)-1-[(3E,5S)-5-[(4-hydroxyphenyl)methyl]-2,4-dioxopyrrolidin-3-ylidene]-4,8-dimethyltetradeca-2,4,10,12-tetraen-1-olate

C27H32NO4- (434.2331)


   
   
   
   

1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

(8R,9S,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9S,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

(8R,9R,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9R,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

(6S,7S,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H30N4O3 (434.2318)


   

(6R,7R,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H30N4O3 (434.2318)


   

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

C25H30N4O3 (434.2318)


   

[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone

[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone

C25H30N4O3 (434.2318)


   

cyclohexyl-[(2S,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclohexyl-[(2S,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)


   

cyclohexyl-[(2R,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclohexyl-[(2R,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)


   

1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

1-[[(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

1-[(4R,7R,8S)-5-ethyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4R,7R,8S)-5-ethyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C23H38N4O4 (434.2893)


   

(8S,9S,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9S,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

(8R,9S,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9S,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

(8R,9R,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9R,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

(8S,9R,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9R,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

(8S,9R,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9R,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

(8S,9S,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9S,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)


   

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone

C25H30N4O3 (434.2318)


   

(6S,7S,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H30N4O3 (434.2318)


   

1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

C25H30N4O3 (434.2318)


   

cyclohexyl-[(2S,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclohexyl-[(2S,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)


   

cyclohexyl-[(2R,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclohexyl-[(2R,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)


   

[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone

[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone

C25H30N4O3 (434.2318)


   
   
   
   
   
   
   
   
   
   

16-(beta-D-Glucopyranosyloxy)hexadecanoic acid

16-(beta-D-Glucopyranosyloxy)hexadecanoic acid

C22H42O8 (434.288)


   

[(4E,8E)-2-acetamido-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-acetamido-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H39N2O6P (434.2546)


   

[(4E,8E)-3-hydroxy-2-(propanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(propanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H39N2O6P (434.2546)


   

13-Oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid

13-Oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid

C21H38O9 (434.2516)


   

1-Oleoylglycerone 3-phosphate

1-Oleoylglycerone 3-phosphate

C21H39O7P (434.2433)


A 1-acylglycerone 3-phosphate in which the acyl group is specified as oleoyl.

   

LysoPA(18:2(9Z,12Z)/0:0)

LysoPA(18:2(9Z,12Z)/0:0)

C21H39O7P (434.2433)


   

(2R)-2-[(2R,3R,4S)-3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-hydroxyethyl dodecanoate

(2R)-2-[(2R,3R,4S)-3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-hydroxyethyl dodecanoate

C22H42O8 (434.288)


   

2-Linoleoyl-glycero-3-phosphate

2-Linoleoyl-glycero-3-phosphate

C21H39O7P (434.2433)


   

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

C25H38O6 (434.2668)


   

1-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

1-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

C21H39O7P (434.2433)


   

lysophosphatidic acid 0:0/18:2(9Z,12Z)

lysophosphatidic acid 0:0/18:2(9Z,12Z)

C21H39O7P (434.2433)


A 2-acyl-sn-glycerol 3-phosphate having (9Z,12Z)-octadeca-9,12-dienoyl as the 2-O-acyl group.

   

1-linoleoyl-sn-glycerol 3-phosphate

1-linoleoyl-sn-glycerol 3-phosphate

C21H39O7P (434.2433)


A 1-acyl-sn-glycerol 3-phosphate having linoleyl (9Z,12Z-octadecadienoyl) as the 1-O-acyl group.

   

1-Oleoyl-sn-glycero-3-phosphate(2-)

1-Oleoyl-sn-glycero-3-phosphate(2-)

C21H39O7P (434.2433)


A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoyl-sn-glycero-3-phosphate.

   

1-stearoylglycerone 3-phosphate(2-)

1-stearoylglycerone 3-phosphate(2-)

C21H39O7P (434.2433)


A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phospho groups of 1-stearoylglycerone 3-phosphate; major species at pH 7.3.

   

2-Oleoyl-sn-glycero-3-phosphate(2-)

2-Oleoyl-sn-glycero-3-phosphate(2-)

C21H39O7P (434.2433)


A 2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-oleoyl-sn-glycero-3-phosphate; major species at pH 7.3.

   

TG(22:4)

TG(6:0_6:0_10:4)

C25H38O6 (434.2668)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

PA O-14:1/4:1

PA O-14:1/4:1

C21H39O7P (434.2433)


   

PA O-16:2/2:0

PA O-16:2/2:0

C21H39O7P (434.2433)


   
   

PA P-14:0/4:1

PA P-14:0/4:1

C21H39O7P (434.2433)


   

PA P-14:0/4:1 or PA O-14:1/4:1

PA P-14:0/4:1 or PA O-14:1/4:1

C21H39O7P (434.2433)


   

PA P-16:1/2:0

PA P-16:1/2:0

C21H39O7P (434.2433)


   

PA P-16:1/2:0 or PA O-16:2/2:0

PA P-16:1/2:0 or PA O-16:2/2:0

C21H39O7P (434.2433)


   
   

PA P-18:1 or PA O-18:2

PA P-18:1 or PA O-18:2

C21H39O7P (434.2433)


   
   
   

ST 19:2;O;Hex

ST 19:2;O;Hex

C25H38O6 (434.2668)


   
   
   
   

INCB38579

INCB38579

C25H34N6O (434.2794)


INCB38579 is an orally active, highly brain penetrable, and selective histamine H4 receptor (HH4R) antagonist (hH4R IC50=4.8 nM, mH4R IC50=42 nM, rH4R IC50=32 nM). INCB38579 shows anti-inflammatory pain and anti-pruritic activities[1].

   

(2r,3r,4ar,6ar,8s,10r,10ar,10bs)-3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

(2r,3r,4ar,6ar,8s,10r,10ar,10bs)-3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-(hydroxymethyl)-6-[(3,10,11-trihydroxy-3,7,11-trimethyldodeca-1,6-dien-5-yl)oxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[(3,10,11-trihydroxy-3,7,11-trimethyldodeca-1,6-dien-5-yl)oxy]oxane-3,4,5-triol

C21H38O9 (434.2516)


   

(2r,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

(2r,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4ar,5r,8r,8as)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4ar,5r,8r,8as)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)


   

2-benzoyl-3,5-dihydroxy-4,4,6-tris(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

2-benzoyl-3,5-dihydroxy-4,4,6-tris(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C28H34O4 (434.2457)


   

(2r)-3-hydroxy-2-[(9z,12z)-octadeca-9,12-dienoyloxy]propoxyphosphonic acid

(2r)-3-hydroxy-2-[(9z,12z)-octadeca-9,12-dienoyloxy]propoxyphosphonic acid

C21H39O7P (434.2433)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)


   

2,3-dihydroxy-6a,6b,8a,11,12b-pentamethyl-10-oxo-8,9,11,12,12a,13-hexahydro-7h-picene-4-carbaldehyde

2,3-dihydroxy-6a,6b,8a,11,12b-pentamethyl-10-oxo-8,9,11,12,12a,13-hexahydro-7h-picene-4-carbaldehyde

C28H34O4 (434.2457)


   

{5-ethenyl-1,5,7,12,12-pentamethyl-11-[(2-methylbut-2-enoyl)oxy]-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl}acetic acid

{5-ethenyl-1,5,7,12,12-pentamethyl-11-[(2-methylbut-2-enoyl)oxy]-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl}acetic acid

C25H38O6 (434.2668)


   

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2e)-2-methylbut-2-enoate

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2e)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

[(1s,4r,5r,9r,10r,13r)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

[(1s,4r,5r,9r,10r,13r)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O3 (434.2821)


   

[(1s,4r,5r,9r,10r,13r)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

[(1s,4r,5r,9r,10r,13r)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O3 (434.2821)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(3s,5s,6e,10r)-3,10,11-trihydroxy-3,7,11-trimethyldodeca-1,6-dien-5-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(3s,5s,6e,10r)-3,10,11-trihydroxy-3,7,11-trimethyldodeca-1,6-dien-5-yl]oxy}oxane-3,4,5-triol

C21H38O9 (434.2516)


   

3-benzoyl-4-hydroxy-6,6-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

3-benzoyl-4-hydroxy-6,6-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C28H34O4 (434.2457)


   

(1r,5r,10r,16r,18r)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

(1r,5r,10r,16r,18r)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

(8as,11s,12ar,12bs,14as)-3,11-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydropicene-2,10-dione

(8as,11s,12ar,12bs,14as)-3,11-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydropicene-2,10-dione

C28H34O4 (434.2457)


   

3-ethyl-2-{9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

3-ethyl-2-{9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)


   

3,10-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-10,11,12,12a,13,14-hexahydro-8h-picene-2,9-dione

3,10-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-10,11,12,12a,13,14-hexahydro-8h-picene-2,9-dione

C28H34O4 (434.2457)


   

7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s,8as)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s,8as)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)


   

(6as,6bs,8as,11r,12ar,12bs)-2,3-dihydroxy-6a,6b,8a,11,12b-pentamethyl-10-oxo-8,9,11,12,12a,13-hexahydro-7h-picene-4-carbaldehyde

(6as,6bs,8as,11r,12ar,12bs)-2,3-dihydroxy-6a,6b,8a,11,12b-pentamethyl-10-oxo-8,9,11,12,12a,13-hexahydro-7h-picene-4-carbaldehyde

C28H34O4 (434.2457)


   

(2z,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

(2z,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

C25H38O6 (434.2668)


   

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)


   

7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl 2-methylbut-2-enoate

7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-(hydroxymethyl)-6-[(2,11,12-trihydroxy-2,6-dimethyl-10-methylidenedodec-6-en-3-yl)oxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[(2,11,12-trihydroxy-2,6-dimethyl-10-methylidenedodec-6-en-3-yl)oxy]oxane-3,4,5-triol

C21H38O9 (434.2516)


   

3,4-diethyl-5-(2-ethyl-4-phenylbuta-1,3-dien-1-yl)-1,5,7-trimethyl-2-oxo-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

3,4-diethyl-5-(2-ethyl-4-phenylbuta-1,3-dien-1-yl)-1,5,7-trimethyl-2-oxo-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C29H38O3 (434.2821)


   

(1s,2r,5r,10r,13s,14s,16s,17r,20s,21r,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

(1s,2r,5r,10r,13s,14s,16s,17r,20s,21r,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


   

(1r,5ar,7r,8r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-7-{[(2r)-2-methylbutanoyl]oxy}-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl (2z)-2-methylbut-2-enoate

(1r,5ar,7r,8r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-7-{[(2r)-2-methylbutanoyl]oxy}-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3,11-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydropicene-2,10-dione

3,11-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydropicene-2,10-dione

C28H34O4 (434.2457)


   

3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-(4,6-dimethyloct-6-en-2-yl)-6-oxo-2,3-dihydropyran-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

2-(4,6-dimethyloct-6-en-2-yl)-6-oxo-2,3-dihydropyran-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)


   

(2s,3s,4r,5r)-2-{[(5r,8s)-2-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{[(5r,8s)-2-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

{5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate

{5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H38O3 (434.2821)


   

2-[(1as,2r,2ar,5's,6ar,7s,7as)-7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

2-[(1as,2r,2ar,5's,6ar,7s,7as)-7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1e)-2-[(1s,2s,7s)-2-(4-hydroxy-4-methylpentyl)-5-(hydroxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

(1e)-2-[(1s,2s,7s)-2-(4-hydroxy-4-methylpentyl)-5-(hydroxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-{[(2s,4as,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

3-{[(2s,4as,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

C25H38O6 (434.2668)


   

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2e)-2-methylbut-2-enoate

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2e)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

methyl (2e,6e)-6-methyl-9-(7-methyl-5,8-dioxonaphthalen-2-yl)-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoate

methyl (2e,6e)-6-methyl-9-(7-methyl-5,8-dioxonaphthalen-2-yl)-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoate

C28H34O4 (434.2457)


   

1-hydroxy-6,6,9a-trimethyl-7-[(2-methylbutanoyl)oxy]-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl 2-methylbut-2-enoate

1-hydroxy-6,6,9a-trimethyl-7-[(2-methylbutanoyl)oxy]-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-{[(2s,4ar,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

3-{[(2s,4ar,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

C25H38O6 (434.2668)


   

6,15-dihydroxy-4-(2-methylpropyl)-13-(sec-butyl)-19-oxa-2,5,11,14-tetraazatetracyclo[8.8.1.0²,¹⁶.0⁷,¹¹]nonadeca-5,14-diene-3,12-dione

6,15-dihydroxy-4-(2-methylpropyl)-13-(sec-butyl)-19-oxa-2,5,11,14-tetraazatetracyclo[8.8.1.0²,¹⁶.0⁷,¹¹]nonadeca-5,14-diene-3,12-dione

C22H34N4O5 (434.2529)


   

(2r,3e,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2r,3e,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)


   

2-[(4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl)oxy]oxane-3,4,5-triol

2-[(4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl)oxy]oxane-3,4,5-triol

C25H38O6 (434.2668)


   

8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

C25H38O6 (434.2668)


   

3-hydroxy-4,6b,8a,11,11,12b,14a-heptamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

3-hydroxy-4,6b,8a,11,11,12b,14a-heptamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C29H38O3 (434.2821)


   

2,10-dihydroxy-2,6,10-trimethyl-3-[(2-methylbut-2-enoyl)oxy]dodeca-6,8,11-trien-4-yl 2-methylbut-2-enoate

2,10-dihydroxy-2,6,10-trimethyl-3-[(2-methylbut-2-enoyl)oxy]dodeca-6,8,11-trien-4-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 2-methylbut-2-enoate

3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1r,3br,4r,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1r,3br,4r,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H34O4 (434.2457)


   

4-[(3r,4ar,4bs,6as,7s,10ar,10bs,12as)-1-hydroxy-7-(hydroxymethyl)-4b,7,10a-trimethyl-tetradecahydrophenanthro[2,1-c]pyran-3-yl]-5-hydroxy-5h-furan-2-one

4-[(3r,4ar,4bs,6as,7s,10ar,10bs,12as)-1-hydroxy-7-(hydroxymethyl)-4b,7,10a-trimethyl-tetradecahydrophenanthro[2,1-c]pyran-3-yl]-5-hydroxy-5h-furan-2-one

C25H38O6 (434.2668)


   

5,7-dihydroxy-2-[(4z,7z,10z,13z,16z)-nonadeca-4,7,10,13,16-pentaen-1-yl]chromen-4-one

5,7-dihydroxy-2-[(4z,7z,10z,13z,16z)-nonadeca-4,7,10,13,16-pentaen-1-yl]chromen-4-one

C28H34O4 (434.2457)


   

1-[8,8a-dimethyl-3-({3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-2-yl}oxy)-4,4a,5,6,7,8-hexahydro-1h-naphthalen-2-yl]ethanone

1-[8,8a-dimethyl-3-({3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-2-yl}oxy)-4,4a,5,6,7,8-hexahydro-1h-naphthalen-2-yl]ethanone

C29H38O3 (434.2821)


   

7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

methyl({2-[(1r,2s,11r,13s)-3,3,13-trimethyl-18-[2-(methylamino)ethyl]-4,14-dioxapentacyclo[11.7.1.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]henicosa-5,7,9,15,17,19-hexaen-8-yl]ethyl})amine

methyl({2-[(1r,2s,11r,13s)-3,3,13-trimethyl-18-[2-(methylamino)ethyl]-4,14-dioxapentacyclo[11.7.1.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]henicosa-5,7,9,15,17,19-hexaen-8-yl]ethyl})amine

C28H38N2O2 (434.2933)


   

(2s)-2-amino-4-{[(1r)-1-{[({3-[(4-aminobutyl)amino]propyl}-c-hydroxycarbonimidoyl)methyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-{[({3-[(4-aminobutyl)amino]propyl}-c-hydroxycarbonimidoyl)methyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H34N6O5S (434.2311)


   

(6bs,8as,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,11,12b,14a-heptamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

(6bs,8as,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,11,12b,14a-heptamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C29H38O3 (434.2821)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s,8ar)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s,8ar)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)


   

2-{2-hydroxy-6,10-dimethyl-4-[(2-methylbut-2-enoyl)oxy]-11-oxabicyclo[8.1.0]undec-6-en-3-yl}propyl 2-methylbut-2-enoate

2-{2-hydroxy-6,10-dimethyl-4-[(2-methylbut-2-enoyl)oxy]-11-oxabicyclo[8.1.0]undec-6-en-3-yl}propyl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(2s)-2-[(2s)-n,3-dimethyl-2-(methylamino)butanamido]-n-[2-(1h-indol-3-yl)ethyl]-3-phenylpropanimidic acid

(2s)-2-[(2s)-n,3-dimethyl-2-(methylamino)butanamido]-n-[2-(1h-indol-3-yl)ethyl]-3-phenylpropanimidic acid

C26H34N4O2 (434.2682)


   

3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-6a,8,9,11,12,12a,13,14-octahydropicene-2,6,10-trione

3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-6a,8,9,11,12,12a,13,14-octahydropicene-2,6,10-trione

C28H34O4 (434.2457)


   

methyl (4as,4br,7r,7ar,10ar,11r,12as)-11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

methyl (4as,4br,7r,7ar,10ar,11r,12as)-11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

C25H38O6 (434.2668)


   

[(3as,3bs,5as,9as,9br,10s,11as)-10-(acetyloxy)-6,6,9a,11a-tetramethyl-2-oxo-decahydro-3h-phenanthro[2,1-b]furan-3b-yl]methyl acetate

[(3as,3bs,5as,9as,9br,10s,11as)-10-(acetyloxy)-6,6,9a,11a-tetramethyl-2-oxo-decahydro-3h-phenanthro[2,1-b]furan-3b-yl]methyl acetate

C25H38O6 (434.2668)


   

(1s,2r,4r,5s,8r,9s,13r,14s,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

(1s,2r,4r,5s,8r,9s,13r,14s,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)


   

(1s,2r,5r,10r,13s,16s,17r,20s,21s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

(1s,2r,5r,10r,13s,16s,17r,20s,21s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

C25H38O6 (434.2668)


   

1-[(1s,2r,4as,8ar)-1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[(1s,2r,4as,8ar)-1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H38O6 (434.2668)


   

6-hydroxy-3,3,7,9-tetramethyl-5-[(2-methylbutanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl 2-methylbut-2-enoate

6-hydroxy-3,3,7,9-tetramethyl-5-[(2-methylbutanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

methyl (1s,4ar,5s,8ar)-5-[(4s)-4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

methyl (1s,4ar,5s,8ar)-5-[(4s)-4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H38O6 (434.2668)


   

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

(1r,5r,7r)-3-benzoyl-4-hydroxy-6,6-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

(1r,5r,7r)-3-benzoyl-4-hydroxy-6,6-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C28H34O4 (434.2457)


   

2-{[5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)


   

12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

C25H38O6 (434.2668)


   

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8r)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8r)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)


   

4-[2-(methylamino)ethyl]-2-{6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl}phenol

4-[2-(methylamino)ethyl]-2-{6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl}phenol

C28H38N2O2 (434.2933)


   

2-[(6ar,7s,10ar)-6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl]-4-[2-(methylamino)ethyl]phenol

2-[(6ar,7s,10ar)-6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl]-4-[2-(methylamino)ethyl]phenol

C28H38N2O2 (434.2933)


   

(2s,3r,4s,5r)-2-{[(4bs,8as)-4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5r)-2-{[(4bs,8as)-4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

[(1s,2s,5s,7s,9s,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

[(1s,2s,5s,7s,9s,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

C25H38O6 (434.2668)


   

methyl 6-methyl-9-(7-methyl-5,8-dioxonaphthalen-2-yl)-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoate

methyl 6-methyl-9-(7-methyl-5,8-dioxonaphthalen-2-yl)-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoate

C28H34O4 (434.2457)


   

3-({5-[5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl}oxy)-3-oxopropanoic acid

3-({5-[5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl}oxy)-3-oxopropanoic acid

C25H38O6 (434.2668)


   

1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H34O4 (434.2457)


   

(1r,2r,5r,10r,14r,16r,17s,18r,21s)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

(1r,2r,5r,10r,14r,16r,17s,18r,21s)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

(8as,11r,12ar,12bs,14ar)-3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-6a,8,9,11,12,12a,13,14-octahydropicene-2,6,10-trione

(8as,11r,12ar,12bs,14ar)-3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-6a,8,9,11,12,12a,13,14-octahydropicene-2,6,10-trione

C28H34O4 (434.2457)


   

(1s,2s,3s,5s,8s,10s,14s)-2-(acetyloxy)-5,10-dihydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl propanoate

(1s,2s,3s,5s,8s,10s,14s)-2-(acetyloxy)-5,10-dihydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl propanoate

C25H38O6 (434.2668)


   

(2s,3s,4r,5r)-2-{[(5r,8s)-1-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{[(5r,8s)-1-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

2-{7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl}ethyl 3-methylbut-2-enoate

2-{7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl}ethyl 3-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

methyl 5-[4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

methyl 5-[4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H38O6 (434.2668)


   

(1s,2r,4r,5s,9s,13r,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

(1s,2r,4r,5s,9s,13r,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)


   

(1s,4s,5r,9s,10r,12r,13s,14s)-12,14-dihydroxy-5,9-dimethyl-14-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

(1s,4s,5r,9s,10r,12r,13s,14s)-12,14-dihydroxy-5,9-dimethyl-14-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H38O6 (434.2668)


   

(1r)-1-[(1r,2r,5r,7r,8r,10s,11r,14s,15r)-8-(acetyloxy)-10,11-dihydroxy-2,15-dimethylpentacyclo[8.7.0.0²,⁷.0⁵,⁷.0¹¹,¹⁵]heptadecan-14-yl]ethyl acetate

(1r)-1-[(1r,2r,5r,7r,8r,10s,11r,14s,15r)-8-(acetyloxy)-10,11-dihydroxy-2,15-dimethylpentacyclo[8.7.0.0²,⁷.0⁵,⁷.0¹¹,¹⁵]heptadecan-14-yl]ethyl acetate

C25H38O6 (434.2668)


   

3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)


   

(8ar,10r,11r,12as,12bs,14as)-3,10-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-10,11,12,12a,13,14-hexahydro-8h-picene-2,9-dione

(8ar,10r,11r,12as,12bs,14as)-3,10-dihydroxy-4,7,8a,11,12b,14a-hexamethyl-10,11,12,12a,13,14-hexahydro-8h-picene-2,9-dione

C28H34O4 (434.2457)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8r,8ar)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8r,8ar)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)


   

methyl(2-{3,3,13-trimethyl-8-[2-(methylamino)ethyl]-4,14-dioxapentacyclo[11.7.1.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]henicosa-5,7,9,15,17,19-hexaen-18-yl}ethyl)amine

methyl(2-{3,3,13-trimethyl-8-[2-(methylamino)ethyl]-4,14-dioxapentacyclo[11.7.1.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]henicosa-5,7,9,15,17,19-hexaen-18-yl}ethyl)amine

C28H38N2O2 (434.2933)


   

(1s,4s,7s,10s,13s,16s)-4-[(2s)-butan-2-yl]-6,15-dihydroxy-13-(2-methylpropyl)-19-oxa-2,5,11,14-tetraazatetracyclo[8.8.1.0²,¹⁶.0⁷,¹¹]nonadeca-5,14-diene-3,12-dione

(1s,4s,7s,10s,13s,16s)-4-[(2s)-butan-2-yl]-6,15-dihydroxy-13-(2-methylpropyl)-19-oxa-2,5,11,14-tetraazatetracyclo[8.8.1.0²,¹⁶.0⁷,¹¹]nonadeca-5,14-diene-3,12-dione

C22H34N4O5 (434.2529)


   

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1r,3r,3ar)-1,3-dihydroxy-1-isopropyl-3a,6-dimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydroazulen-4-yl (2z)-2-methylbut-2-enoate

(1r,3r,3ar)-1,3-dihydroxy-1-isopropyl-3a,6-dimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydroazulen-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1s,2r,5r,10r,14s,16s,17r,20s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

(1s,2r,5r,10r,14s,16s,17r,20s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


   

2-[n,3-dimethyl-2-(methylamino)butanamido]-n-[2-(1h-indol-3-yl)ethyl]-3-phenylpropanimidic acid

2-[n,3-dimethyl-2-(methylamino)butanamido]-n-[2-(1h-indol-3-yl)ethyl]-3-phenylpropanimidic acid

C26H34N4O2 (434.2682)


   

1-[(4ar,8s,8ar)-8,8a-dimethyl-3-{[(5s)-3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-2-yl]oxy}-4,4a,5,6,7,8-hexahydro-1h-naphthalen-2-yl]ethanone

1-[(4ar,8s,8ar)-8,8a-dimethyl-3-{[(5s)-3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-2-yl]oxy}-4,4a,5,6,7,8-hexahydro-1h-naphthalen-2-yl]ethanone

C29H38O3 (434.2821)


   

2-amino-4-[(1-{[({3-[(4-aminobutyl)amino]propyl}-c-hydroxycarbonimidoyl)methyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl)-c-hydroxycarbonimidoyl]butanoic acid

2-amino-4-[(1-{[({3-[(4-aminobutyl)amino]propyl}-c-hydroxycarbonimidoyl)methyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl)-c-hydroxycarbonimidoyl]butanoic acid

C17H34N6O5S (434.2311)


   

5-methoxy-2,4-dimethyl-6-[(1r,6r)-4-(4-methylpent-3-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol

5-methoxy-2,4-dimethyl-6-[(1r,6r)-4-(4-methylpent-3-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol

C28H34O4 (434.2457)


   

12,14-dihydroxy-5,9-dimethyl-14-{[(2-methylbut-2-enoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

12,14-dihydroxy-5,9-dimethyl-14-{[(2-methylbut-2-enoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H38O6 (434.2668)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(3r,6e,11s)-2,11,12-trihydroxy-2,6-dimethyl-10-methylidenedodec-6-en-3-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(3r,6e,11s)-2,11,12-trihydroxy-2,6-dimethyl-10-methylidenedodec-6-en-3-yl]oxy}oxane-3,4,5-triol

C21H38O9 (434.2516)


   

2-[(6as,7r,10ar)-6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl]-4-[2-(methylamino)ethyl]phenol

2-[(6as,7r,10ar)-6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl]-4-[2-(methylamino)ethyl]phenol

C28H38N2O2 (434.2933)


   

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(2s,3z,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2s,3z,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)


   

[(1r,2s,5s,7s,9r,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

[(1r,2s,5s,7s,9r,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

C25H38O6 (434.2668)


   

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2z)-2-methylbut-2-enoate

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1s,3s,3ar,4r,5r,7ar)-3,4-diethyl-5-[(1e,3e)-2-ethyl-4-phenylbuta-1,3-dien-1-yl]-1,5,7-trimethyl-2-oxo-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5r,7ar)-3,4-diethyl-5-[(1e,3e)-2-ethyl-4-phenylbuta-1,3-dien-1-yl]-1,5,7-trimethyl-2-oxo-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C29H38O3 (434.2821)


   

(6as,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-6a,8,9,11,12,12a,13,14-octahydropicene-2,6,10-trione

(6as,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-6a,8,9,11,12,12a,13,14-octahydropicene-2,6,10-trione

C28H34O4 (434.2457)


   

(1r,2s,4s,5s,6s,7r,8s,9r)-6-hydroxy-3,3,7,9-tetramethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl (2z)-2-methylbut-2-enoate

(1r,2s,4s,5s,6s,7r,8s,9r)-6-hydroxy-3,3,7,9-tetramethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(2r,3r,12bs)-3-ethyl-2-{9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2r,3r,12bs)-3-ethyl-2-{9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)


   

(2s)-2-[(1r,2r,3s,4s,6e,10s)-2-hydroxy-6,10-dimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxabicyclo[8.1.0]undec-6-en-3-yl]propyl (2z)-2-methylbut-2-enoate

(2s)-2-[(1r,2r,3s,4s,6e,10s)-2-hydroxy-6,10-dimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxabicyclo[8.1.0]undec-6-en-3-yl]propyl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-{[1-hydroxy-3,8-dimethyl-5-(6-methylhept-5-en-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

2-{[1-hydroxy-3,8-dimethyl-5-(6-methylhept-5-en-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

1-[1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H38O6 (434.2668)


   

1-{[(3-oxoundecyl)sulfanyl]disulfanyl}undecan-3-one

1-{[(3-oxoundecyl)sulfanyl]disulfanyl}undecan-3-one

C22H42O2S3 (434.2347)


   

methyl 11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

methyl 11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

C25H38O6 (434.2668)


   

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

5-methoxy-2,4-dimethyl-6-[(1r,6r)-3-(4-methylpent-3-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol

5-methoxy-2,4-dimethyl-6-[(1r,6r)-3-(4-methylpent-3-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol

C28H34O4 (434.2457)